Coccidioidomycosis, also known as Valley fever, is a fungal infection caused by inhaling spores of Coccidioides species, affecting the lungs and potentially spreading, resulting in various symptoms such as fever, cough, and fatigue.
Hyperbaric oxygen therapy may enhance the immune response and optimize antifungal drug delivery, potentially improving outcomes in coccidioidomycosis patients.